Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
Tuesday, April 06, 2021Sorrento Therapeutics Incannounced the signing of a merger agreement pursuant to which Sorrento will acquire ACEA Therapeutics Inc ACEA The acquisition will include late clinical stage drug Abivertinib clinical stage candidate AC preclinical stage ca...
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Saturday, April 03, 2021Supernus Pharmaceuticals Inc a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases today announced that the US Food and Drug Administration FDA approved Qelbree viloxaz...
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19
Saturday, April 03, 2021Emergent BioSolutions Inc provided an update on the evaluation of its investigational SARSCoV Immune Globulin Intravenous Human COVIDHIG for the treatment of hospitalized patients with COVID The Phase Inpatient Treatment with AntiCoronavirus Immunog...
Bioasis Technologies Inc. and Aposense Enter into a Research Collaboration
Thursday, April 01, 2021Bioasis Technologies Inc a preclinical researchstage biopharmaceutical company developing its proprietary xB TM platform technology for the delivery of therapeutics across the bloodbrain barrier BBB and the treatment of CNS disorders in areas of high...
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology
Thursday, April 01, 2021BridgeBio Pharma Inc through its affiliate QED Therapeutics Inc and Helsinn Group announced a global collaboration and licensing agreement the Agreement to further develop and commercialize QED Therapeutics FGFR inhibitor infigratinib in oncology an...
BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for "Undruggable" Targets
Wednesday, March 31, 2021BridGene Biosciences Inc a biotechnology company using cuttingedge technology to discover and develop small molecules for hardtodrug therapeutic targets announced a strategic research collaboration and licensing agreement with Takeda Pharmaceutical C...
Applied BioMath, LLC Announces Collaboration with Asher Biotherapeutics for Systems Pharmacology Modeling in Oncology
Wednesday, March 31, 2021Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced a collaboration with Asher Biotherapeutics for systems pharmac...
Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China
Tuesday, March 30, 2021Tarsus Pharmaceuticals Inc a late clinicalstage biopharmaceutical company and LianBio a biotechnology company dedicated to bringing paradigmshifting medicines to patients in China and major Asian markets announced a strategic partnership to develop a...
Hansa Biopharma enters preclinical research collaboration with argenx
Tuesday, March 30, 2021Hansa Biopharma AB Hansa a pioneer in enzyme technology for rare immunological conditions announced that they have entered into a preclinical research collaboration agreement with argenx BV to evaluate the therapeutic potential of combining the two c...
Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
Monday, March 29, 2021Astellas Pharma Incannounced the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending an additional indication for the oral oncedaily therapy XTANDITM enzalutamide for ad...
